Menstrual Health and Vitality: Breaking the Silence, Stemming the Flood
A large section of people from the Mithapukur region, over 300 people, young girls and women, female and male teachers and local and national media attended the 'Labonno' project training and capacity building workshop. Credit: News NetworkBy Archana PatkarvGENEVA, May 23 2017 (IPS)Menstruation matters to everyone, everywhere. But it still matters so much more to women and girls, who have historically been asked to bleed in stoic silence so that no one even knows they have their period. It is slowly but surely becoming socially acceptable to start talking about periods, a biological fact as old as womankind itself— even as the United Nations commemorates Menstrual Hygiene Day on May 28.Society is finally coming of age and suddenly everyone is coming out about their vaginas.At the Women Deliver conference in 2016, Jessica Biel bemoaned the world’s reluctance to talk openly about women’s bodies. “[Body talk is] very shameful, and that’s the problem — why is it so shameful?” she asked. “I feel completely embarrassed talking about this stuff, even with my gynecologist, and why is that? It makes no sense. I am here because I want to pull the stigmas off female reproductive everything.”For every celebrity willing to break the silence, slow and steady web chatter is successfully whittling down those deep prejudices and walls that we have built at the intersection of multiple biases. Take male sexual identity and preference and ad...
[Guardian] A recent study has shown how substandard drug used to stop post partum haemorrhage (PPH) fuels maternal deaths in Nigeria. Earlier studies had identified PPH as the leading cause of maternal mortality across the country.
[New Era] Opuwo -The Kazetjindire Angelika Muharukua maternity waiting home at Opuwo is a dream come true for the women of Kunene, who were used to travelling long distances to give birth, or otherwise had to do so at home. But the maternity shelter will now allow expectant mothers to move closer to the Opuwo hospital, where they can live while receiving professional care as they wait for the delivery of the child.
This article aims to discuss the problem of AF in dialysis patients, summarise the current evidence around the use of oral anticoagulants for AF in ESRD and provide some practical suggestions on management of AF in the haemodialysis population.
Scientists are peering into the brains of "superagers" in the hope of finding ways to protect others from memory loss
Summary A few decades ago, the chances of survival for patients with a haematological malignancy needing Intensive Care Unit (ICU) support were minimal. As a consequence, ICU admission policy was cautious. We hypothesized that the long‐term outcome of patients with a haematological malignancy admitted to the ICU has improved in recent years. Furthermore, our objective was to evaluate the predictive value of the Acute Physiology and Chronic Health Evaluation (APACHE) II score. A total of 1095 patients from 5 Dutch university hospitals were included from 2003 until 2015. We studied the prevalence of patients' characteristi...
ConclusionsQuinolones are not associated with unfavourable pregnancy outcomes; however, larger studies are needed before safety is established. Until then, it is suggested that quinolones should not be used as a first‐line therapy during the first trimester. Tweetable abstractQuinolones were associated with favourable pregnancy outcomes; caution should be taken in the first trimester.
The Hibernating Bear—A Good Analogy to Explain Why Acute Fatty Liver of Pregnancy Manifests in Late Pregnancy American Journal of Gastroenterology 113, 307 (February 2018). doi:10.1038/ajg.2017.462 Authors: Uday Zachariah, Ashish Goel, K A Balasubramanian &C E Eapen
In conclusion, pregnant endometriosis patients should be offered special clinical attention.
ConclusionsThe findings obtained in the present study suggest that an increased intake of low‐fat but not regular‐fat cheese between pre‐pregnancy and early pregnancy is associated with a lower risk of GDM in high‐risk women.
Conclusions Although TND is simple, safe, and less invasive than LOD, its effect on ovarian reserve appears to be transient and diminishes at 6 months. Multicenter studies are warranted to confirm efficacy as second-line treatment in patients with CC-resistant PCOS. (Pan African Clinical Trials Registry http://www.pactr.org PACTR2017020020135137)